Stocktoria
IMPACT BIOMEDICAL INC. IBO
NYSE American · XASE · stock · Pharmaceutical Preparations · website · IPO 2024-09-16
IMPACT BIOMEDICAL INC. statistics & valuation
Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating margin | -13381.2% | — | — | -6808.0% |
| Net margin | -36993.8% | — | — | -14510.0% |
| Return on assets | -68.0% | -121.8% | -9.7% | -15.6% |
| Return on equity | -76.1% | -341.4% | -15.3% | -22.2% |
| Current ratio | 0.35 | 0.25 | 0.03 | 0.01 |
Source: SEC EDGAR filings · CIK 0001834105 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.